US pharmaceutical company Johnson & Johnson could submit an official application for its vaccine against COVID-19 to the European Medicines Agency (EMA) in February, according to the bloc’s Health chief, Stella Kyriakides.
While the approval of jab developed by J&J could mark the EU’s fourth COVID-19 vaccine, it is “vaccinations” and not the vaccine itself that will save lives, Kyriakides said, Reuters reported, citing Peter Liese, an EU lawmakers who speaks on health matters for the…
This story is part of New Europe’s Premium content.
| To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑ |
In this article:
